PIA stands for “Programme d’Investissements d’Avenir” (Future Investment Programme). Launched in 2010 by the French government, this programme aims to fund innovative projects in key sectors for the economy and society. Its objectives include strengthening research excellence, enhancing technology transfer, supporting training and employment, accelerating the ecological transition, and modernising public services.
More information here.
FI stands for “France Innovation”. FI 2030 is a new phase of the PIA, launched in 2021 to continue the efforts initiated in 2010. This programme focuses on developing innovative solutions to address major societal challenges.
More information here.
Which fundings for France-BioImaging?
In 2024, as part of the PIA FI 2030 framework, the French Ministry of Higher Education and Research allocated 80 M€ for a call dedicated to the National Research Infrastructures in Biology and Health to keep their research and technologies at the highest level of excellence.
France BioImaging was a laureate of the call with its project Biological Imaging Next-Generation Instruments (BIOGENI).
In this project, 1.9 M€ will be invested to rejuvenate and upgrade existing technologies and 7.3 M€ will serve to implement new technologies, paving the way for the use of next-generation imaging methods by our users.
What does BIOGENI project aim to?
The BIOGEN project will both strengthen the visibility and attractivity of France-BioImaging, and provide our researchers access to the most powerful and needed imaging technologies.
This includes new technologies in super-resolution and single molecule tracking, multiscale correlative microscopy, light sheet microscopies, high-content and multiplexed imaging, new contrasts and preclinical microscopy.
The equipment purchased thanks to BIOGENI will be complemented by new human resources dedicated to data management and image analysis, provided by the Partner Institutions of the infrastructure.
This will enable proper data management and analysis, as many of the new technologies deliver very large datasets requiring dedicated tools.
Check out France-BioImaging’s strategic goals to learn more about BIOGENI project.